Author

Paul J. Baratta

Observed name: PJ Baratta

Observed institutions: Mount Sinai Hospital, Mayo Clinic, Duke University, University of Michigan, Princess Margaret Cancer Centre, Dana-Farber Cancer Institute, U-M Rogel Cancer Center, University of Pennsylvania

OpenAlex ID: A5081744643

Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms

2017 · Costanza Paoletti, Andi K. Cani, et al. · Cancer Research · 106

Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial

2017 · C Paoletti, MM Regan, et al. · Cancer Research · 10

Data from Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms

2023 · Costanza Paoletti, Andi K. Cani, et al.

Supplementary Data from Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms

2023 · Costanza Paoletti, Andi K. Cani, et al.

Supplementary Data from Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms

2023 · Costanza Paoletti, Andi K. Cani, et al.

Abstract 3151: Genetic profiling of circulating tumor cells (CTC) in metastatic breast cancer (MBC) patients

2016 · Costanza Paoletti, Andi K. Cani, et al. · Cancer Research

Works count: 6

Citation count: 116

H-index: 2

I10-index: 2